EAHAD 2025 4 - 7 February 2025

Efficacy and safety of concizumab prophylaxis in patients with haemophilia and inhibitors: Results from the Early Access Program in France

Authors :

Alexandre Butelet¹; Nicolas Béranger²; Vincent Cussac²; Roseline d’Oiron^3-6; Yesim Dargaud^4-5; Victoria Delerue²; Stéphanie Desage⁵; Caroline Galeotti³; Sophie Susen⁷; Valérie Chamouard^4-5

Affiliations

View Details Hide Details

Keywords

Rare Blood Disorders

Congress poster

Concizumab

Are you a healthcare professional?

Efficacy and safety of concizumab prophylaxis in patients with haemophilia and inhibitors: Results from the Early Access Program in France